DRKS00025969尚未招募4 期
A prospective, multicenter clinical study comparing outcomes of two trifocal toric intraocular lens - BTVCPL-TRITORIC-2019-18
Biotech Europe Meditech Inc. Ltd.0 个研究点目标入组 84 人开始时间: 2021年8月4日最近更新:
适应症
试验速览
- 阶段
- 4 期
- 状态
- 尚未招募
- 发起方
- 入组人数
- 84
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized controlled study
- 盲法
- Open (masking not used)
入排标准
- 年龄范围
- 21 Years 至 one(—)
- 性别
- All
入选标准
- •1. Age of patient >21 Years
- •2. Patient diagnosed with cataract.
- •3. Patient must have preoperative regular corneal astigmatism between 0.75 to 4.5 D as per corneal topography or keratometry
- •4. Calculated IOL power is within the range of investigational IOLs.
- •5. Patient willing to sign inform consent form.
- •6. Clear intraocular media other than cataract.
- •7. Female participants of childbearing potential must be willing to ensure that they use effective contraception during the study.
排除标准
- •1. Previous intraocular or corneal surgery.
- •2. Traumatic cataract
- •3. Pregnancy (as stated by patient) or lactation.
- •4. Concurrent participation in another drug or device investigation.
- •5. Irregular astigmatism.
- •6. Patient receiving chlorquine treatment.
- •7. Subjects with any systemic disease that could increase operative risk or confound the outcome.
- •8. Active ocular disease in the operative eye other than cataract.
- •9. Vulnerable subjects as defined in section 12.3.9.
- •10. Corneal Astigmatism > 4.5 D
研究者
相似试验
尚未招募
4 期
A trial comparing two trifocal toric intraocular lensCTRI/2022/02/040590Biotech Healthcare Holdings GmbH
尚未招募
不适用
Multicenter, prospective, randomized study comparing motorized spiral enteroscopy with double balloon enteroscopyK63.8K92.2Other specified diseases of intestineGastrointestinal haemorrhage, unspecifiedDRKS00025890Medizinische Klinik 1 Universitätsmedizin Frankfurt32
招募中
不适用
Comparative study between Diode Laser Surgery and Filtering Surgery as a Primary Surgical Procedure for patients with GlaucomaOpen Angle GlaucomaC11.525.381C11.525.381.407RBR-65rzrvCentro de Referência em Oftalmologia da Universidade Federal de Goiás (CEROF-UFG)
进行中(未招募)
1 期
INTOReTAK : INfliximab and TOcilizumab in Refractory/relapsing TAKayasu arteritisPatients with refractory or relapsing Takayasu Arteritis deseaseEUCTR2018-003753-13-FRASSISTANCE PUBLIQUE - HOPITAUX DE PARIS50
进行中(未招募)
不适用
A trial in which will be studied if the addition of a medicine that is used for improving platelet counts (eltrombopag) to the regular treatment for aplastic anemia (hATG + CsA) also improves the numbers of other cell lines and therefore the overall bone marrow function.Idiopathic (Severe) Aplastic Anemia, a bone marrow failure syndrome which results in the normal hematopoietic tissue completely missing from the bone marrow, accounting for the subsequent pancytopenia.MedDRA version: 18.0Level: PTClassification code 10002967Term: Aplastic anaemiaSystem Organ Class: 10005329 - Blood and lymphatic system disordersEUCTR2014-000363-40-ESEuropean Society for Blood and Marrow Transplantation200
